Moderna Inc CMV Interim Data Conference Call Transcript
Good morning, and welcome to the Moderna CMV 7-month Interim Data Conference Call. (Operator Instructions) Please be advised that the call is being recorded.
At this time, I'd like to turn the call over to Lavina Talukdar, Head of Investor Relations at Moderna. Please proceed.
Thank you, Shannon. Good morning and happy new year, everyone. At today's conference call, we will review 7-month interim data from the company's Phase I CMV vaccine program. You can access the press release issued yesterday as well as the slides that we'll be reviewing by going to the Investors section of our website.
Speaking on the call today will be Stéphane Bancel, Chief Executive Officer; and Tal Zaks, Chief Medical Officer. Also present in the room is Lorence Kim, Chief Financial Officer.
Before we begin, I would like to remind you that this conference call will include forward-looking statements. Please see Slide 2 of the accompanying presentation and our SEC filings for important factors that could cause
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |